Quantum Biopharma (QNTM) Other Working Capital Changes (2019 - 2026)

Quantum Biopharma has disclosed Other Working Capital Changes across 8 years of filings, most recently posting $76183.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $76183.0, up 201.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $76183.0 (down 6.24% YoY), and the FY2025 annual result was $15290.0, down 77.85% from the prior year.
• Other Working Capital Changes came in at $76183.0 for Q1 2026 at Quantum Biopharma, up from $24004.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.6 million in Q1 2022 to a low of -$117683.0 in Q1 2024.
• The 5-year median for Other Working Capital Changes is $192953.0 (2023), against an average of $429631.2.
• Across the five-year window, Other Working Capital Changes surged 1475.19% in 2022 and plunged 114.05% in 2024, its largest moves.
• Quantum Biopharma's Other Working Capital Changes stood at $584306.0 in 2022, then sank by 66.98% to $192953.0 in 2023, then tumbled by 57.87% to $81289.0 in 2024, then tumbled by 70.47% to $24004.0 in 2025, then jumped by 217.38% to $76183.0 in 2026.
• The last three Other Working Capital Changes figures came in at $76183.0 (Q1 2026), $24004.0 (Q4 2025), and $39294.0 (Q3 2025), per Business Quant data.